CN
Search
Home
About
Integrity and Compliance
Solutions
Products
Education
ESG
ESG Report
ESG Story
Patients
Conditions
Procedure Overview
Patient Stories
News
Company News
Industry News
Events
Careers
Investor Relations
Announcement & Circulars
Prospectus & Financial Report
Corporate Information
Presentation Materials
Financial Calendar & Contact
Contact Us
Home
About
About Us
Integrity and Compliance
Solutions
Products
Neurovascular Interventions
Vascular Interventions
Education
Neurovascular Cases
Vascular Intervention Cases
ESG
ESG Report
2025 Environmental, Social, and Governance Report
2024 Environmental, Social, and Governance Report
ESG Story
Bringing Hope to the Life of a Young Father After Stroke
''Her Power'' Shines, Advancing with Zylox-Tonbridge towards Boundless Possibilities
Photovoltaic Power Support, Green Manufacturing Starts on the Roof
Patients
Conditions
Neuro
Vascular
Procedure Overview
Tigereye ST Explainer Video
Pantheris Animation- Atherectomy Device Removing Plaque from Peripheral Artery Disease. PML0290 F
Patient Stories
PTA Balloon Catheter Basics
Peripheral Vascular Treatment
IVC Filter Device Basics
What Devices for Vascular Interventions Are There?
The Technical Principle of PTA Balloon
PTA Catheters in the Management of Hemodialysis Access
Global Market Analysis for Neurovascular Interventions
What Are the Stages of the Development of Vascular Stents?
What Do Vascular Interventions Include? What Precautions Should Be Taken Before Treatment?
Development History of Vascular Stents
How to Distinguish Between Vascular Stents and Thrombectomy Stents?
What Diseases Can Peripheral Vascular Intervention Treat? What Are the Advantages?
Selection of PTA Balloon Diameter for Arteriovenous Fistula
Indications and Complications of Vascular Interventional Therapy
What Are the Precautions for Patients Undergoing Peripheral Vascular Interventional Surgery?
What is Peripheral Vascular Intervention?
Extensive Application and Treatment Methods of Peripheral Vascular Interventional Therapy
An Article to Understand Peripheral Vascular Interventional Medicine
Coil Embolization of Cerebral Aneurysms
Introduction to Peripheral Vascular Disease and Interventional Therapy
Commonly Used Devices for Neurointerventional Therapy
What Are the Advantages of Neurovascular Interventional Therapy?
Treatment and Common Issues of Neurovascular Intervention
How Neurological Interventions Save Lives?
PAD Stent Surgery Basic Info
Aspira Catheter Instructions
Interventional Measures for Neurovascular Intervention
How is Coil Embolization Performed?
Coil Embolization for the Treatment of Arterial Aneurysms
What is Coil Embolization?
Endovascular Revascularization Procedure
The Future Prospect of the Neurointervention Industry in the Market
Neurointervention: The Crown Jewel of Interventional Surgery
Why Do More People Choose Radial Artery as the Access Site for Vascular Intervention Procedures?
The Significance and Advantages of Neurovascular Intervention
What Are the Indications for Neurovascular Intervention?
PTA Catheters' Role in Iliac and Femoropopliteal Interventions
Peripheral Stent Systems in Renal Artery Intervention Treatment
News
Company News
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
Zylox-Tonbridge's ZYLOX Venous Stent System Receives NMPA Marketing Approval
The 2023 Investor Open Day of Zylox-Tonbridge Was Successfully Held
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan
Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index
Approval Granted for Full Circulation of Zylox-Tonbridge H shares, Significantly Raising its Circulation Market Capitalization
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 Million and Gross Profit Reaches RMB 253 Million
Zylox-Tonbridge Enters into Strategic Cooperation with Hicicare for Innovative Chinese Vascular Guidewires Solutions
Zylox-Tonbridge's Strategic Investment in Wire Sciences Boosts the Development of Innovative Vascular Intervention Surgical Robots
ZYLOX-TONBRIDGE Postdoctoral Workstation was Officially Inaugurated to Help Cultivate High-level Talents in the Medical Device Industry
ZYLOX-TONBRIDGE Completed Patient Enrollment for Its Flow Diverter Clinical Trial in Less Than Five Months
ZYLOX-TONBRIDGE Holds First Investor Day Event to Explore Development Opportunities for Domestic Substitution
Zylox-Tonbridge successfully holds the national launch meeting for Tonbridge Gekko™ Coil System
ZYLOX-TONBRIDGE Made Exclusive Technology Collaboration with SKY ROAD to Enrich its Product Portfolio
Zylox-Tonbridge: Neurovascular Embolization Coils obtains NMPA approval for marketing in advance, demonstrating the strong R&D capabilities
Zylox-Tonbridge: Talent recruitment to gather pace upon approval of H-share incentive trust scheme by General Shareholders' Meeting
Zylox-Tonbridge Sets up Beijing Office and Shanghai R&D Center to Attract High-Quality Talents and Strive for Rapid Development
Zylox-Tonbridge: Tonbridge Gycline™ Microcatheter Obtains Marketing Authorization from NMPA Ahead of Schedule
Zylox-Tonbridge completes patient enrollment in the PEVENSEY study for Zynlastic™ peripheral venous stent system
Zylox-Tonbridge Brings a New Option for Overseas Patients with Acute Ischemic Stroke
2021 ZYLOX-TONBRIDGE INDUSTRIAL PARK OPENING CEREMONY
TonBridge Medical was selected as a technology-based SMEs in Guangdong
SWEDEPAD Interim Analysis Shows No Mortality Difference Found for Paclitaxel-Coated Devices.
TonBridge Medical won the Science and Technology Innovation Leader of 2020 and Science and Technology Innovation Product of 2020
TonBridge Medical obtained the certificate of intellectual property management system certification
Zylox Medical's Staff ran the 2020 Hangzhou Dream Town Half Marathon
TonBridge Medical won two Bronze Award of
Zylox Medical's ZENFluxion™ and ZENFLEX Pro™ Received CE Certificate
TonBridge Medical was promoted as an industrial enterprise above designated size
Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery
TonBridge Medical held a launch meeting for the Clot Retriever Device and the Intracranial Support Catheters
The Intracranial Support Catheter obtained medical device registration certificate
The Clot Retriever Device obtained medical device registration certificate
ThromBite™ gained CE certificate
Zylox-TonBridge Medical was selected as one of the top 50 most valuable investment companies in China in 2019
TonBridge Medical won the runner-up of the 2018 China Innovation and Entrepreneurship Competition in Biomedical Industry Finals (medical device group champion)
Zylox Medical wins Second prize in the 6th China Innovation and Entrepreneurship Competition
Zylox Medical Receives CE Mark for ZENFlex Peripheral Stent System
Zylox-Tonbridge: Approval for Commercialization of Multiple Products Enabled 544% Year-on-year Revenue Growth for the Company in 2021
Zylox-Tonbridge: PTA Balloon Catheter — Large Diameter Obtains Marketing Approval from NMPA
Tonbridge Webinar：BGC in Transradial Neurointerventions
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22
Zylox-Tonbridge Receives Approval to Launch ZYLOX Octoplus™ IVC Filter from NMPA
Zylox-Tonbridge's ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series
Zylox-Tonbridge Completed Patient Enrollment for ZENFLEX® Peripheral Stent System Clinical Trial in the EU
Zylox-Tonbridge's ZYLOX® Phoenix Peripheral Detachable Fibered Coil Embolization System Receives NMPA Marketing Approval
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
Zylox-Tonbridge 2024 Investor Open Day Successfully Held in Hangzhou
ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia
2024 Environmental, Social and Governance Report
Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 115 Million in 1H 2025 Net Profit
Seeing is Believing | First Case of Pantheris Completed in Boao, Hainan
Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year
Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy
Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market
Zylox-Tonbridge Announces Positive Profit Alert: Net Profit Expected to Increase by Approximately 140% Year-on-Year in FY2025, with Revenue Exceeding RMB 1.05 Billion
Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey
From Mom and Dad's Workplace to a Wider World: A Summer Camp for Zylox-Tonbridge Families
Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%
Industry News
FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed
The Summit Forum for Smarter Healthcare Development in Wuhan
2016 First China Drug Scientific Regulatory Congress
Pay Attention to Top 10 Health Technological Hazards for 2017
PTA Catheters in the Management of Carotid Artery Stenosis
Peripheral Stents Released: Solutions for Lower Extremity Arterial Disease
Neurovascular Coils Transforming Aneurysm Therapy in South America
Cerebral Coil Embolization for the Treatment of Intracranial Vascular Abnormalities
Peripheral Stent Systems In Oncology: Navigating Interventional Radiology For Global Patients
The Rising Trend of Peripheral Stent Systems in Modern Medicine
Future Market Prospects of Intracranial Aneurysm Coiling
High-Pressure PTA Balloon Catheter Market Analysis Report
The Prospect of Intracranial Thrombus Aspiration Catheter: Growth Opportunities and Future Outlook
Current Situation, Growth Opportunities, and Future Market Prospects of Intracranial Support Catheters
Focusing on the Future Path of Peripheral Vascular Interventions
Industry Landscape and Opportunity Analysis of Drug-Eluting Balloon Catheters
The Current Situation and Future Market Prospects of Vascular Snare
Regional Distribution of the Neurovascular Devices Market
Interpretation of the Industry for Thrombectomy Stents
Neurovascular Interventions in the International Market
What Is the Difference Between Distal Access Catheters and Intracranial Support Catheters?
PTA Balloon Catheter Global Market Analysis Report
Neurovascular Interventional Catheter Market Analysis Report
Analysis of Global Trends in Neurological Medical Devices Market
Analysis and Development Trends of the Global Peripheral Stent Market
Coil Procedure for Cerebral Aneurysm: A Common Endovascular Treatment
The Industry Development of Vascular Embolization Coils in Different Regions
Neurointervention Basics: Cerebral Coil Embolization
Application of Neuro Medical Devices on a Global Scale
Analysis of the Impact of Innovation in Neurological Medical Devicess on Market Development
Analysis of the Global Market Development for Peripheral Vascular Devices
Application and Technical Advancements of PTA Balloon Dilatation Catheter
Analysis of the Market Development Prospects of Stent Retriever
Neurovascular Coils: A Vascular Disease Doctor's Weapon
Reasons for the Growth of the Thrombus Aspiration Catheter Market and Development of Diverse Applications
The Application Value of Peripheral Spring Coil in Peripheral Aneurysms
Development and Classification of Peripheral Spring Rings
Events
Careers
Investor Relations
Announcement & Circulars
Dissemination of Corporate Communications
Notice Of Board Meeting
Announcement Regarding The H Share Full Circulation Listing Approval Granted By The Stock Exchange
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Voluntary Announcement - Unaudited Operating Statistics For The Year Ended December 31, 2021
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 December 2021
Voluntary Announcement - The Strategic Investment In Wire Sciences
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 November 2021
Voluntary Announcement Completion Of Patient Enrollment For The Flow Diverter Clinical Trial
Voluntary Announcement Intention Of The Chairman To Increase Shareholding In The Company
Inside Information Announcement Approval By The Csrc Of The Company's Application For The Full Circulation Of H Shares
Voluntary Announcement - Collaboration Agreement With Sky Road
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 October 2021
An Announcement Has Just Been Published By The Issuer In The Chinese Section Of This Website, A Corresponding Version Of Which May Or May Not Be Published In This Section
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 September 2021
Notification Letter and Request Form to Non-registered Shareholders
Interim Report 2021
Voluntary Announcement National Medical Products Administration Granted Marketing Approval For Neurovascular Embolization Coils In China
Articles Of Association
Poll Results Of The 2021 Third Extraordinary General Meeting
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 August 2021
Form Of Proxy For 2021 Third Extraordinary General Meeting
Notice Of 2021 Third Extraordinary General Meeting
(1) Proposed Adoption Of The 2021 H Share Award And Trust Scheme; (2) Proposed Authorization To The Board And/or The Delegatee To Handle Matters Pertaining To The 2021 H Share Award And Trust Scheme; (3) Proposed Amendments To The Articles Of Association;
(1) Proposed Adoption Of The 2021 H Share Award And Trust Scheme; (2) Proposed Authorization To The Board And/or The Delegatee To Handle Matters Pertaining To The 2021 H Share Award And Trust Scheme; (3) Proposed Change Of Registered Address; (4) Proposed
Interim Results Announcement For The Six Months Ended June 30, 2021
Notice Of Board Meeting
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 July 2021
Voluntary Announcement Unaudited Operating Statistics For The Period From January 1, 2021 To June 30, 2021
Next Day Disclosure Return
Full Exercise Of The Over-allotment Option, Stabilizing Actions And End Of Stabilization Period
Voluntary Announcement Completion Of Patient Enrollment For The Clinical Trial Of Zynlastic Peripheral Venous Stent System
List Of Directors And Their Roles And Functions
Terms Of Reference For The Nomination Committee
Terms Of Reference For The Remuneration Committee
Terms Of Reference Of The Audit Committee
Articles Of Association
Announcement Of Offer Price And Allotment Results
Green Application Form
Global Offering
Global Offering
PHIP (1st Submission)
PHIP (1st Submission)1
Application Proof (1st Submission)
Application Proof (1st Submission)
Voluntary Announcement Unaudited Operating Statistics For The Year Ended December 31, 2021
Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities
Announcement Regarding Completion Of The H Share Full Circulation
Announcement Of Annual Results For The Year Ended December 31, 2021
Next Day Disclosure Return - July
Post Hearing Information Pack of Zylox-Tonbridge Medical Technology Co., Ltd.
Application Proof of Zylox-Tonbridge Medical Technology Co., Ltd.
Annual Report 2021
CIRCULAR OF 2021 ANNUAL GENERAL MEETING, 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES AND 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
NOTICE OF 2021 ANNUAL GENERAL MEETING
NOTICE OF 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES
NOTICE OF 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
FORM OF PROXY FOR 2021 ANNUAL GENERAL MEETING
FORM OF PROXY FOR 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES
FORM OF PROXY FOR 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR PTA BALLOON CATHETER - LARGE DIAMETER IN CHINA
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE 2021 H SHARE AWARD AND TRUST SCHEME
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING, THE 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES AND 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
CHANGE OF ADDRESS OF H SHARE REGISTRAR
UPDATE ANNOUNCEMENT IN RELATION TO THE AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
ARTICLES OF ASSOCIATION
NOTICE OF BOARD MEETING
Interim Report 2023
UPDATE ON QUALIFICATION OF THE JOINT COMPANY SECRETARY
Prospectus & Financial Report
ZYLOX-TONBRIDGE ANNUAL REPORT 2025
ZYLOX-TONBRIDGE INTERIM REPORT 2025
ZYLOX-TONBRIDGE ANNUAL REPORT 2024
ZYLOX-TONBRIDGE INTERIM-REPORT 2024
ZYLOX-TONBRIDGE ANNUAL REPORT 2023
ZYLOX-TONBRIDGE INTERIM REPORT 2023
ZYLOX-TONBRIDGE ANNUAL REPORT 2022
ZYLOX-TONBRIDGE INTERIM REPORT 2022
ZYLOX-TONBRIDGE ANNUAL REPORT 2021
ZYLOX-TONBRIDGE INTERIM REPORT 2021
ZYLOX-TONBRIDGE PROSPECTUS
Corporate Information
Procedures for Shareholders to Nominate a Person for Election as a Director
Presentation Materials
2026 Interim Results Presentation
2025 Annual Results Presentation
2025 Interim Results Presentation
2024 Annual Results Presentation
2024 Interim Results Presentation
2023 Annual Result Presentation
2023 Interim Results Presentation
2022 Interim Results Presentation
2022 Annual Results Presentation
2021 Annual Results Presentation
Financial Calendar & Contact
The Upcoming
The Past Record
Contact
Contact Us
Email Us
+86-571-8861-0082
info@zyloxtb.com
Contact Us
About
About Us
Integrity and Compliance
Solutions
Neurovascular Interventions
Ischemic Stroke
Hemorrhagic Stroke
Intracranial Stenosis
Carotid Artery Stenosis
Intracranial Access
Radial Artery Access
Vascular Interventions
Arterial
Venous
Hemodialysis Access
Other Peripheral-Vascular
Vascular Closure Devices
Education
Neurovascular Cases
Vascular Intervention Cases
ESG
Patients
News
Company News
Industry News
Events
Careers
Investor Relations
Announcement & Circulars
Prospectus & Financial Report
Corporate Information
Presentation Materials
Financial Calendar & Contact
EN
CN
Financial Calendar & Contact
Home
Investor Relations
Financial Calendar & Contact
Contact
Announcement & Circulars
Prospectus & Financial Report
Corporate Information
Presentation Materials
Financial Calendar & Contact
The Upcoming
The Past Record
Contact
E-mail:
ir@zyloxtb.com
SUBMIT
+86-571-8861-0082
info@zyloxtb.com
Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou, Zhejiang, China
Tonbridge Medical
optimed
Solutions
Neurovascular Interventions
Ischemic Stroke
Hemorrhagic Stroke
Intracranial Stenosis
Carotid Artery Stenosis
Intracranial Access
Radial Artery Access
Vascular Interventions
Arterial
Venous
Hemodialysis Access
Other Peripheral-Vascular
Vascular Closure Devices
Quick Links
About
ESG
Patients
Investor Relations
News
Contact Us
Neurovascular Interventions
Ischemic Stroke
Hemorrhagic Stroke
Intracranial Stenosis
Carotid Artery Stenosis
Intracranial Access
Radial Artery Access
Vascular Interventions
Arterial
Venous
Hemodialysis Access
Other Peripheral-Vascular
Vascular Closure Devices
Quick Links
About
ESG
Patients
Investor Relations
News
Contact Us
Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou, Zhejiang, China
info@zyloxtb.com
+86-571-8861-0082
+86-571-8861-0082
We use cookies on this site, including third party cookies, to delivery experience for you.
Accept Cookies
Read Privacy Policy
Your browser does not support VBScript!
.webp)